SHR3162
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SHR3162, covering 2025-01-24 to 2025-06-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC [Phase 2]